- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Dynatronics Corporation (DYNT)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: DYNT (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $4
1 Year Target Price $4
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -22.22% | Avg. Invested days 11 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.85M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 1 | Beta 0.35 | 52 Weeks Range 0.04 - 0.19 | Updated Date 12/8/2025 |
52 Weeks Range 0.04 - 0.19 | Updated Date 12/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.37 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -40.04% | Operating Margin (TTM) -1.26% |
Management Effectiveness
Return on Assets (TTM) -7.15% | Return on Equity (TTM) -127.4% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14972304 | Price to Sales(TTM) 0.03 |
Enterprise Value 14972304 | Price to Sales(TTM) 0.03 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA -7.1 | Shares Outstanding 16048734 | Shares Floating 7397503 |
Shares Outstanding 16048734 | Shares Floating 7397503 | ||
Percent Insiders 53.36 | Percent Institutions 2 |
Upturn AI SWOT
Dynatronics Corporation

Company Overview
History and Background
Dynatronics Corporation was founded in 1979, initially focusing on manufacturing and distributing therapeutic equipment for the physical therapy market. Over the years, it has evolved to offer a broader range of products and services for healthcare professionals, including orthopedic devices, surgical implants, and sports medicine products. A significant milestone was its acquisition by AcuMetrix Corporation in 2008, which aimed to leverage AcuMetrix's expertise in medical device manufacturing. Dynatronics has since continued to expand its product portfolio through organic growth and strategic partnerships.
Core Business Areas
- Orthopedics: Dynatronics designs, manufactures, and markets a comprehensive line of orthopedic implants and instruments for various surgical procedures, including sports medicine, joint reconstruction, and trauma. This segment also includes related surgical tools and implants for spine, extremities, and biologics.
- Physical Therapy and Rehabilitation: This segment encompasses the sale of a wide range of therapeutic equipment, modalities, and supplies used by physical therapists, athletic trainers, and other healthcare professionals for patient rehabilitation and pain management. This includes ultrasound, electrical stimulation, and exercise equipment.
- Sports Medicine: Dynatronics provides specialized products and solutions for athletes and sports medicine practitioners, focusing on injury prevention, treatment, and performance enhancement. This includes bracing, taping supplies, and diagnostic equipment.
Leadership and Structure
Dynatronics Corporation is led by a management team with expertise in the medical device and healthcare industries. The organizational structure is typically segmented to align with its core business areas, allowing for specialized focus and operational efficiency.
Top Products and Market Share
Key Offerings
- Product Name 1: Orthopedic Implants (e.g., Joint Replacement, Trauma Fixation) - Dynatronics offers a range of implants for knees, hips, shoulders, and extremities, as well as fixation devices for fractures. Market share is fragmented, with key competitors including Stryker, Zimmer Biomet, and Johnson & Johnson. Specific revenue figures for individual product lines are not readily available publicly. Competitors: Stryker (SYK), Zimmer Biomet (ZBH), Johnson & Johnson (JNJ) - Medical Devices segment.
- Product Name 2: Therapeutic Modalities (e.g., Ultrasound, Electrical Stimulation) - These devices are used in physical therapy clinics for pain relief and rehabilitation. The market is competitive with companies like Mettler Electronics and DJO Global. Revenue contribution is part of the broader rehabilitation equipment segment. Competitors: Mettler Electronics, DJO Global.
- Product Name 3: Sports Medicine Bracing and Taping - Dynatronics provides a variety of braces, supports, and taping products for injury prevention and management in sports. Competitors in this space include Bauerfeind and Mueller Sports Medicine. Competitors: Bauerfeind, Mueller Sports Medicine.
Market Dynamics
Industry Overview
The medical device industry, particularly in orthopedics and rehabilitation, is characterized by innovation, regulatory scrutiny, and consolidation. Growing aging populations, increasing prevalence of chronic diseases, and advancements in surgical techniques are driving demand. The sports medicine segment is also experiencing growth due to increased participation in sports and a greater focus on injury prevention and recovery.
Positioning
Dynatronics Corporation positions itself as a provider of innovative and cost-effective solutions for orthopedic and rehabilitation needs. Its competitive advantages lie in its integrated product portfolio, commitment to research and development, and established relationships with healthcare providers. However, it operates in a highly competitive landscape with larger, more established players.
Total Addressable Market (TAM)
The total addressable market for orthopedic implants and rehabilitation equipment is substantial, estimated to be in the tens of billions of dollars globally, with significant portions in North America. Dynatronics addresses a segment of this TAM, focusing on specific product categories and customer bases. Its market share within the broader industry is relatively small compared to major players, but it holds a stronger position within its niche segments.
Upturn SWOT Analysis
Strengths
- Established presence in niche orthopedic and rehabilitation markets.
- Integrated product portfolio offering a range of solutions.
- Focus on innovation and product development.
- Relationships with healthcare providers and distributors.
Weaknesses
- Smaller scale compared to major competitors.
- Reliance on third-party manufacturers for some products.
- Limited brand recognition in certain segments.
- Potential for cash flow constraints due to R&D and product launches.
Opportunities
- Expansion into emerging markets.
- Development of new, minimally invasive orthopedic technologies.
- Strategic partnerships and acquisitions to broaden product offerings or market reach.
- Increasing demand for sports medicine and rehabilitation products.
- Leveraging technology for remote patient monitoring and rehabilitation.
Threats
- Intense competition from larger, well-funded medical device companies.
- Stringent regulatory environment and approval processes.
- Healthcare cost containment pressures affecting purchasing decisions.
- Technological obsolescence of existing products.
- Supply chain disruptions and raw material cost volatility.
Competitors and Market Share
Key Competitors
- Stryker (SYK)
- Zimmer Biomet (ZBH)
- Johnson & Johnson (JNJ)
- DJO Global (Part of Enovis Corporation - ENOV)
- Smith+Nephew (SNN - UK Listed, but significant US presence)
Competitive Landscape
Dynatronics faces intense competition from larger, more established players with significant financial resources, extensive distribution networks, and broader product portfolios. Its advantages lie in its agility, specialization in certain niches, and potentially more personalized customer service. However, it faces challenges in competing on scale, R&D investment, and broad market penetration.
Growth Trajectory and Initiatives
Historical Growth: Dynatronics Corporation's historical growth has likely been influenced by product introductions, market penetration, and potentially strategic acquisitions or divestitures. Investors should examine historical revenue and net income trends to understand past performance.
Future Projections: Future growth projections for Dynatronics Corporation would typically come from analyst reports and company guidance, focusing on anticipated market trends, new product pipelines, and strategic initiatives. These projections are subject to market conditions and execution risk.
Recent Initiatives: Recent initiatives might include the launch of new product lines, expansion into new geographic markets, or investments in R&D to develop next-generation medical devices. Specific initiatives would be detailed in company press releases and investor presentations.
Summary
Dynatronics Corporation operates in the competitive medical device and rehabilitation sector, focusing on orthopedics and physical therapy. Its strengths lie in its integrated product offerings and niche market focus. However, it faces significant challenges from larger competitors and market pressures. The company's success hinges on its ability to innovate, expand its market reach, and manage its operational costs effectively to drive sustainable growth and profitability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Financial News Websites (e.g., Yahoo Finance, Bloomberg)
- Industry Analysis Reports (general market trends)
- Company Investor Relations
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Market share data is an estimation and may vary based on reporting methodologies. Financial performance figures and future projections are subject to change and market volatility. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Dynatronics Corporation
Exchange NASDAQ | Headquaters Eagan, MN, United States | ||
IPO Launch date 1994-04-25 | CFO, CEO, President, Principal Accounting Officer & Director Mr. Brian D. Baker | ||
Sector Healthcare | Industry Medical Devices | Full time employees 88 | Website https://www.dynatronics.com |
Full time employees 88 | Website https://www.dynatronics.com | ||
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

